"Clinical Experience for ""One-stop"" Performance of Thoracic Endovascular Aortic Repair and Coronary Artery Bypass Grafting"
10.3969/j.issn.1000-3614.2017.06.007
- VernacularTitle:"""一站式""行胸主动脉腔内修复术联合冠状动脉旁路移植术的临床经验"
- Author:
Mingyao LUO
;
Qian CHANG
;
Cuntao YU
;
Xiaogang SUN
;
Xiangyang QIAN
;
Lei CHEN
;
Bingyang JI
;
Haitao ZHANG
;
Kun FANG
;
Zhou ZHOU
;
Chang SHU
- Keywords:
Coronary artery bypass grafting;
Angloplasty;
Thoracic aorta
- From:
Chinese Circulation Journal
2017;32(6):556-559
- CountryChina
- Language:Chinese
-
Abstract:
Objective: To explore the safety and strategy of thoracic endovascular aortic repair (TEVAR) combining coronary artery bypass grafting (CABG) as one-stop performance in treating the patients with coronary artery disease (CAD) and thoracic aorta disease. Methods: A total of 20 patients received one-stop treatment of TEVAR combining CABG in our hospital from 2009-04 to 2016-01 were retrospectively analyzed. There were 18 male and the mean age of patients was (65.2±8.5, 51-82) years. The performance strategy and peri-operative management were studied. Results: There were 1/20 patient received 2 stents implantation in thoracic aorta and 19 received 1 stent in thoracic aorta those including 1 case with endovascular repair of abdominal aortic aneurysm, 1 with right iliac artery stent implantation and 1 with carotid endarterectomy at meanwhile. The average number of coronary artery bypass branch was (2.4±0.94, 1-4) and 10 (50%) patients received internal mammary artery grafting. The average in-hospital time in all 20 patients was (22.4±11.6, 8-58) days. There were 6 (30%) patients received blood transfusion; 1 (5%) having low cardiac output syndrome received extracorporeal membrane oxygenation (ECMO), then received the second thoracotomy for hemostasis due to excessive pleural effusion; 2 (10%) patients died at 30 days post-operation. 1 patient lost contact and 17 received clinical or telephone follow-up visit at the average of (13.4+13.6, 1-49) months; 2 patients died for cerebral hemorrhage at 12 and 49 months post-operation, the rest 15 had disappeared symptoms and improved quality of life, no operation related death occurred. Conclusion: TEVAR combining CABG as one-stop performance presented good mid-term effect in treating the patients with CAD and thoracic aorta disease; in otherwise, the operative time and risk might be increased by two step performance.
